Robert Dumitrescu, Marc Matar, Rainer Opgen-Rhein, Samuel Calderwood

Robert Dumitrescu, Partner, Simon-Kucher & Partners (Paris)Dr. Marc Matar, Partner, Simon-Kucher & Partners (London)Dr. Dr. Rainer Opgen-Rhein, Senior Director, Simon-Kucher & Partners (Munich)Dr. Samuel Calderwood, Consultant, Simon-Kucher & Partners (London)


COVID-19: Risks for Pharma Commercialization

Identifying and acting on the risks developing in the major markets in light of COVID-19 disruption and the implications for assets in late-stage clinical development and early commercialization.